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On histopathological examination, nasal polyps and nasal mucosa in allergic rhinitis show different forms 
of pseudostratifi ed respiratory epithelium, whereas the dominant characteristic of lamina propria is an 
eosinophilic infi ltration. The aim of this study was to compare interleukin (IL)-5 and eosinophilic cationic 
protein (ECP) levels in the nasal fl uid of 42 patients: 12 with allergic rhinitis and nasal septal deviation, 
17 non-atopic patients with nasal polyposis, and 13 atopic nasal polyp patients were enrolled in this cross-
sectional study. Nasal secretion samples were collected a few days before surgery. The levels of IL-5 were 
measured using fl ow cytometry and the ECP using a commercial ELISA kit. In addition, we counted 
eosinophils in hematoxylin-and-eosin-stained sections of all nasal polyp and all nasal mucosa samples 
taken from the inferior nasal turbinates during septoplasty. A signifi cantly higher concentration of IL-5 
was found in the nasal fl uid of atopic patients with nasal polyposis than in non-atopic nasal polyp patients 
(p=0.025) and patients with allergic rhinitis (p=0.05). ECP was higher in atopic nasal polyp patients than 
in patients with allergic rhinitis (p<0.0001) and than in non-atopic nasal polyp patients (p<0.0001). Polyp 
eosinophils were higher in atopic’ than in non-atopic patients (p<0.0001) and higher than in the mucosa 
of patients with allergic rhinitis (p<0.0001). These however had signifi cantly more mucosal eosinophils 
than was found in the polyps of non-atopic patients’ (p=0.025). ECP levels in nasal fl uid and eosinophil 
counts in tissue specimens correlated well in all three groups of patients. Our study has shown that atopic 
nasal polyp patients have a higher level of eosinophilic infl ammation than non-atopic patients with nasal 
polyps and patients with allergic rhinitis.
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Allergic rhinitis is the most common atopic disease 
in the human population as it affects one in four people 
worldwide (1, 2). Its prevalence in the European 
countries ranges between 15 % and 25 %, with a 
tendency to rise by about 3.5 % with every decade (3). 
It is a type I allergic reaction mediated by mast cell-
bound immunoglobulin E (IgE) with a typical helper 
T-cell type 2 (Th2) profi le (3).
Nasal polyposis is characterised by the proliferation 
of pseudostratifi ed respiratory epithelium, thickening 
of the basement membrane, oedema, proliferation of 
fi broblasts, focal fi brosis, and infl ammatory infi ltration 
of the lamina propria (4). The stromal layer of the 
polyp tissue includes mixed infl ammatory cells. The 
predominant histological form of nasal polyposis is 
the eosinophilic type, with an incidence of about 90 % 
(5). The non-eosinophilic form of nasal polyps is much 
less common and the dominant cells in the stroma are 
lymphocytes and plasmocytes (5). Polyps usually 
originate from the anterior ethmoid sinus and descend 
into the nasal cavity through the middle meatus, 
causing symptoms such as nasal obstruction, anosmia, 
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sneezing, rhinorrhoea, and itching (4). The aetiology 
of nasal polyposis is not well known, but may involve 
several potential factors such as chronic persistent 
inflammation and oxidative stress. Inflammation 
triggers include bacterial, fungal and viral infection, 
allergy, and environmental pollution (6, 7).
Ramanathan et al. (8) suggest that increased 
presence of eosinophils is associated with ineffective 
local T helper (Th) 1-based immune response (8). 
Weakened Th1 response in nasal polyp patients may 
follow the down-regulation of specific toll-like 
receptors (TLR) involved in immune response. Nasal 
polyposis, which affects about 2.7 % of the European 
adult population, usually manifests itself after the age 
of 20 years (7).
Nasal secretion is the fi rst line of nasal mucosa 
defence (9). It contains small amounts of cytokines 
and other inflammatory mediators, produced by 
epithelial and immunocompetent cells. These peptides 
are involved in the regulation of infl ammation and 
immune defence.
Tissue eosinophilia is the general characteristic of 
allergic rhinitis and of 80 % to 90 % of nasal polyps. 
Activated eosinophils produce and secrete different 
vasoactive substances, cytokines, chemotactic factors, 
leukotrienes, major basic proteins, eosinophilic 
cationic protein (ECP), and eosinophilic peroxidases 
(EPOs). Kramer et al. (3) suggest that ECP concentration 
reflects eosinophil count and the degree of 
infl ammation.
Interleukin (IL)-5 is a Th2 cytokine that strongly 
affects the differentiation, proliferation, chemotactic 
properties, recruitment into the tissue, and survival of 
eosinophils (3, 4).
The aims of this cross-sectional study were: (a) to 
compare the IL-5 and ECP levels detected in nasal 
fl uid of patients with allergic rhinitis, non-atopic, and 
atopic patients with nasal polyposis; (b) to compare 
the eosinophil counts in the nasal mucosa of patients 
with allergic rhinitis, nasal polyp tissue of non-allergic, 
and in nasal polyp tissue of allergic patients; and (c) 
to see if there is any correlation between the 
infl ammatory mediator levels in nasal secretions and 
eosinophil count in the infl amed tissues.
METHODS
Patients
The study included forty-two (n=42) patients, 12 
with allergic rhinitis and septal deviation, 17 non-
atopic patients and 13 atopic patients with bilateral 
nasal polyposis and indications for surgical treatment. 
All procedures were performed according to the 
Helsinki Declaration. All patients gave their written 
informed consent for participating in the study. The 
study was approved by the Research Ethics Committee 
of the Military Medical Academy, Belgrade, Serbia. 
The diagnosis of bilateral nasal polyposis was based 
on documented medical history and on the results of 
anterior rhinoscopy, nasal endoscopy, and computed 
tomography (CT), according to the current European 
Guidelines (10).
The diagnosis of allergic rhinitis followed the 
guidelines provided by the Allergic Rhinitis and its 
Impact on Asthma (ARIA) initiative (1, 11). It was 
based on the rhinoscopic/endoscopic fi ndings, on the 
positive skin-prick test to commonly inhaled allergens, 
on the presence of symptoms including sneezing, nasal 
itching, nasal congestion/obstruction, rhinorrhoea, 
and/or red and tearing eyes for the last a month (1, 
11).
The exclusion criteria were: antrochoanal polyps, 
bronchial asthma, aspirin sensitivity, cystic fi brosis, 
history of acute respiratory tract infection or treatment 
with oral and topical corticosteroids, antibiotics and 
antihistamines for at least three weeks before 
enrolment, smoking, systemic illness and nasal/sinus 
surgery for at least six months before the start of the 
study.
Allergy determination
The exact atopic status was evaluated in all nasal 
polyp and rhinitis patients on the basis of clinical 
criteria, medical history of allergy, positive skin-prick 
test, and positive serological test. Skin-prick tests were 
performed on the volar part of the forearm with a 
standard battery of common aeroallergens (Soluprick, 
Multi test, Alk-Abello, Denmark) including birch, 
timothy, mugwort (Artemisia vulgaris), dog, cat, 
horse ,  mi te  (Dermatophagoides  far inae , 
Dermatophagoides pteronyssinus), moulds (Alternaria 
alternata, Aspergillus fumigatus, Cladosporium 
herbarum), olive tree, spreading pellitory (Parietaria 
judaica), ribwort plantain (Plantago lanceolata), and 
London planetree (Platanus acerifolia). Skin-prick 
testing also included negative (0.9 % natrium-
chloridum solution) and positive (1 mg mL-1 histamine 
dihydrochloride solution) controls. Reactions were 
read after 15 min, as follows (12): 0 - negative, 
erythema only or no reaction; + - wheal <3 mm; ++ 
- wheal 3 to 5 mm with fl are; +++ - wheal >5 mm to 
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7 mm with fl are; ++++ - wheal >7 mm usually with 
pseudopods and flare. Allergy was diagnosed in 
patients with a wheal diameter at least 3 mm larger 
than that of the negative control, regardless of the 
allergen.
Total serum IgE level was measured using the 
ELISA kit (Elitech Diagnostics, Salon-de-Provence, 
France) and an ELISA reader (Spectra III, Austria). 
Venous blood was collected and centrifuged, and the 
serum stored at -70 °C until testing. Total serum IgE 
levels ≥160 IU mL-1 were considered abnormal (13).
Sampling of nasal secretions and determination of 
IL-5 and ECP
Nasal fl uid samples were collected from the nasal 
cavities of all 42 subjects using a modifi ed absorption 
method (14-16) a few days before surgery. As baseline 
nasal secretion can be scarce in healthy subjects, 
control samples were not taken. All cotton-wool sticks 
with samples were placed in a 2 mL Eppendorf tube 
containing 1 mL of transfer medium (phosphate-
buffered saline with gentamycin 50 μg mL-1, penicillin 
G 340 U mL-1, and fungizone 500 μg mL-1) for 30 min 
to allow for mediators to diffuse into the medium, and 
were then stored at 4 °C for a maximum of 2 h. Nasal 
secretion samples were centrifuged at 1000xg for 10 
minutes to separate cellular components. After that, 
supernatants were stored at -70 °C until mediator 
determination. The concentrations of proinfl ammatory 
Th2 cytokine IL-5 were determined in each of the 42 
samples using a commercial fl ow cytometric kit (Flow 
Cytomix, Bender MedSystems, USA) on the 
cytofl uorimeter (Beckman Coulter XL-MCL, USA) 
according to the manufacturer’s instructions. The 
sensitivity of IL-5 detection was 30 pg mL-1. The 
amount of ECP in the nasal fl uid was measured by 
fluoroimmunoassay (FEIA, UniCAPTM100, 
Pharmacia Diagnostics AB, Uppsala, Sweden), whose 
detection limit was 2 μg L-1.
Tissue preparation and quantifi cation of eosinophils
All the patients were operated on by the same 
surgeon under general anaesthesia. In the allergic 
rhinitis group, nasal mucosa samples were taken from 
the inferior turbinates from patients undergoing 
septoplasty. Nasal polyps located in the middle meatus 
were surgically removed. For histological examination, 
nasal mucosa/polyp samples were fixed in 10 % 
formaldehyde, embedded in paraffi n, cut with the 
microtome into 5-μm sections, and stained with 
haematoxylin and eosin. Histological examination was 
performed using a digital optical microscope (Nikon 
Coolscope, Japan) and a computerised picture analysis 
system. This system was programmed by Image J 
(Java-based image processing program), as described 
elsewhere (17). Once the glass slide was set, brightfi eld 
images could be viewed on the monitor. The visual 
field was oriented along the whole length of the 
epithelium basement membrane. Eosinophils were 
counted in the surface layer of the mucosa at x400 
magnification. The surface layer included the 
pseudostratifi ed respiratory epithelium up to 0.20 mm 
below the basal membrane. The rest of the tissue was 
considered the stromal layer. To yield the mean 
number of eosinophils per high power fi eld (HPF), 10 
randomly chosen HPFs of a single section were 
examined. We counted the eosinophils in the surface 
layer in each section and calculated the average 
number of eosinophils per HPF.
Statistical analysis
Data are expressed as means±standard deviation 
(±SD). A one-way analysis of variance (ANOVA) was 
used to calculate the differences between the three 
groups of patients. We used a post-hoc Dunn-
Bonferroni correction to assess the level of statistical 
difference. A p value of 0.05 and less was considered 
statistically signifi cant. Correlations between IL-5/
ECP levels in nasal secretions and eosinophil counts 
in the nasal polyp/nasal mucosa tissue were evaluated 
using the Pearson’s correlation test. For all statistical 
analysis we used the Stat Plus 2007 programme.
RESULTS
Table 1 shows patient group profi les and skin-prick 
and total serum IgE fi ndings. All patients with allergic 
rhinitis and atopic nasal polyposis were positive to the 
skin-prick test and had increased serum IgE.
Table 2 shows mediator levels in nasal secretion. 
The mean IL-5 level was signifi cantly higher in atopic 
patients with nasal polyposis than in non-atopic 
patients and in patients with allergic rhinitis.
The mean level of ECP was signifi cantly higher in 
atopic nasal polyposis patients than in non-atopic 
patients and patients with allergic rhinitis.
Similarly, eosinophil count in atopic patients was 
significantly higher than in non-atopic patients 
(55.92±5.82 vs. 11.12±2.03, p<0.0001) and patients 
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with allergic rhinitis (55.92±5.82 vs. 16.83±7.89, 
p<0.0001). A signifi cant difference was also found 
between patients with allergic rhinitis and non-atopic 
patients (16.83±7.89 vs. 11.12±2.03, p=0.025) (Table 
3).
Histology seems to confi rm the above fi ndings. 
Figures 1 and 2 show plenty of eosinophils in the 
samples taken from patients with allergic rhinitis and 
atopic nasal polyposis patients, while in non-atopic 
patients eosinophil infi ltration was scarce (Figure 3).
We found no statistically signifi cant correlation 
between IL-5 levels in nasal secretions and eosinophil 
counts. However, the correlation was positive between 
the ECP and eosinophil counts in non-atopic nasal 
polyposis patients and patients with allergic rhinitis 
(Table 4).
Table 1 Patient group profi le
Atopic nasal polyposis Non-atopic nasal polyposis Allergic rhinitis
Patients 13 17 12
Age* / years 43.85±14.37 45.24±14.78 41.47±12.86
Men/Women 8/5 13/4 9/3
Positive skin prick test 100 % (13/13) 0 % (0/17) 100 % (12/12)
Total serum IgE* / IU mL-1 328.93±46.25 68.71±31,84 227.73±48.92
*mean±standard deviation
Table 2 Mediator levels in nasal secretions
Allergic rhinitis Non-atopic nasal polyposis Atopic nasal polyposis
IL-5* / pg mL-1 216.00±275.55a 204.35±285.97b 761.38±885.32
ECP* / μg mL-1 13.67±8.87c 9.00±4.32d 60.08±20.69
*mean±standard deviation
a difference from atopic nasal polyposis p=0.05
b difference from atopic nasal polyposis p=0.025
c,d difference from atopic nasal polyposis p<0.0001
Figure 1  Eosinophils in the surface layer of tunica mucosa 
with many seromucous glands in patients with 
allergic rhinitis (haematoxylin and eosin stain, 
magnifi cation 400x).
Figure 2  Strong eosinophil infi ltration in the surface layer of 
nasal polyp epithelium of atopic patients 
(haematoxylin and eosin stain, magnification 
400x).
Figure 3  Weak eosinophil infiltration in the nasal polyp 
epithelium and lamina propria of non-atopic patients 
(haematoxylin and eosin stain, magnification 
400x).
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DISCUSSION
The prevalence of allergic rhinitis and asthma has 
been increasing in many countries around the world 
(1, 11). Studies vary in reporting the incidence of 
allergy in patients with nasal polyps. Several authors 
found little association between allergy and nasal 
polyps (18-20). In contrast, Bachert et al. (21) 
suggested an association between allergic reaction in 
the infl amed nasal mucosa and increased total and 
specifi c IgE in polyps, without systemic manifestation 
of allergy. Klossek et al. (22) found that allergy was 
signifi cantly more frequent in the nasal polyp patient 
group than in the control group (27.1 % vs. 11.9 %, 
respectively). Asero et al. (23) found that 55 % of nasal 
polyp patients had a positive skin prick test to at least 
one allergen. Jovićević and Kljajić (24) found that 
about 30 % of patients with allergic rhinitis had nasal 
polyposis. Finally, Muñoz del Castillo et al. (25) 
demonstrated a positive skin prick test in 63.2 % of 
190 nasal polyp patients. However, the relationship 
between nasal polyposis and allergy remains 
unclear.
Our study has shown signifi cantly higher IL-5 
levels in the nasal secretions of patients with nasal 
polyposis and allergy than in non-atopic nasal 
polyposis patients. IL-5 seems to play an important 
role in the pathogenesis of allergic rhinitis and nasal 
polyposis, as activates and mobilises eosinophils, and 
stimulates differentiation and growth of B lymphocytes 
(26). Infi ltration and activation of eosinophils are the 
hallmark of nasal polyp tissue (4, 26). Findings 
presented by Fan et al. (4) suggest that T-cell-secreted 
IL-5 and autosecretion of IL-5 from activated 
eosinophils may be the reasons for persistent and 
growing eosinophil infl ammation in the nasal polyp 
tissue. Activated eosinophils release plenty of 
cytotoxic proteins and transforming growth factors 
that cause epithelial injury, basement membrane 
thickening, glandular hyperplasia, stromal fi brosis, 
and angiogenesis (4, 26). Saitoh et al. (27) found a 
significant correlation in eosinophilic infiltration 
between the epithelium and lamina propria. Therefore, 
it is likely that eosinophils migrating into the 
epithelium continue to secrete cytotoxic mediators 
and eventually directly add to the epithelial damage. 
Furthermore, the correlation between eosinophilic 
infi ltration in the epithelium and epithelial damage 
was higher than that between eosinophilic infi ltration 
of the lamina propria and epithelial damage, which 
suggests that epithelial eosinophils may contribute 
much more to an aggressive model of nasal polyposis 
(27).
Our study has shown higher levels of IL-5 and ECP 
in the nasal fl uid of atopic patients with nasal polyposis 
than in patients with allergic rhinitis or non-atopic 
nasal polyposis. Eosinophil count was about three 
times as high as in atopic patient polyps as in the nasal 
mucosa of patients with allergic rhinitis, and about 
four times as high as in non-atopic patient polyps. This 
is in accordance with results presented by Cheng et 
al. (28).
We also found a positive correlation between the 
ECP levels in nasal fl uid and eosinophil counts in all 
three groups of patients, but this correlation was not 
signifi cant in the atopic nasal polyposis patients. While 
ECP is toxic to pathogens, helminth in particular, it 
can also damage airway epithelial cells, elicit local 
oedema, and produce airway hyperreactivity in asthma 
and allergic rhinitis patients (29). It is used as a 
Table 3 Eosinophil counts in nasal mucosa tissue samples




a difference from non-atopic nasal polyposis p<0.025
b,c difference from atopic nasal polyposis p<0.0001
Table 4 Correlation between mediator levels in nasal secretions and eosinophil counts in nasal tissue samples
Mediators EosinophilsAllergic rhinitis Non-atopic nasal polyposis Atopic nasal polyposis






NS: difference not signifi cant
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standard marker of eosinophil activity and is strongly 
involved in upper and lower airway infl ammation, 
such as chronic rhinitis/rhinosinusitis and bronchial 
asthma (30). Rasp et al. (31) found that ECP levels 
were signifi cantly higher in nasal secretions than in 
the serum and are better connected to disease activity 
and prefer ECP determination in nasal fl uid over serum 
to assess the severity of upper airway infl ammation 
(31). Sun et al. (32) demonstrated that ECP levels in 
the nasal fluid of patients with nasal polyposis 
correlated with asthma and aspirin intolerance.
To conclude, allergic nasal polyposis patients in 
our study showed a higher level of eosinophilic 
infl ammation than non-allergic patients with nasal 
polyps or patients with allergic rhinitis. ECP levels in 
nasal fluid correlated well with the number of 
eosinophils and could be useful in evaluating the 
degree of infl ammation in patients with allergic rhinitis 
and in patients with nasal polyposis.
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Sažetak
EOZINOFILNA UPALA U ALERGIJSKOM RINITISU I NOSNOJ POLIPOZI
Na histopatološkim pregledima nosni polipi, kao i nosna sluznica u alergijskom rinitisu pokazuju različite 
oblike pseudoslojevitog respiracijskog epitela, dok je osnovna karakteristika lamine proprije infi ltracija 
eozinofi lima. Cilj ove studije bio je usporediti koncentracije interleukina 5 (IL-5) i eozinofi lnoga kationskog 
proteina (ECP) u nosnome sekretu pacijenata s alergijskim rinitisom, neatopičnih i atopičnih pacijenata s 
nosnom polipozom, kao i usporediti broj eozinofi la u tkivu nosnih polipa/nosne sluznice ovih pacijenata. 
Četrdeset dvoje (n=42) pacijenata, 12-ero s alergijskim rinitisom i devijacijom nosnog septuma, 17-ero 
neatopičnih pacijenata s nosnom polipozom i 13-ero atopičnih pacijenata s nosnom polipozom bilo je 
uključeno u ovu presječnu studiju. Uzorci nosnog sekreta bili su skupljeni iz nosnih šupljina svih ispitanika 
nekoliko dana prije kirurškog liječenja. Koncentracije IL-5 mjerene su metodom protočne citometrije, dok 
su koncentracije ECP mjerene komercijalnim ELISA-kitom. Eozinofi li su brojeni u svim uzorcima tkiva 
nosnih polipa, kao i u svim uzorcima tkiva sluznice uzetih s donje nosne školjke tijekom septoplastike. 
Značajno više koncentracije IL-5 izmjerene su u nosnom sekretu atopičnih pacijenata s nosnom polipozom 
u usporedbi s neatopičnim pacijentima s nosnom polipozom (p=0,025) i pacijentima s alergijskim rinitisom 
(p=0,05). Naši su rezultati pokazali više koncentracije ECP u atopičnih pacijenata s nosnom polipozom 
nego u pacijenata s alergijskim rinitisom (p<0,0001) i u usporedbi s nealergičnim pacijentima s nosnom 
polipozom (p<0,0001). Veći broj eozinofi la izbrojen je u tkivu polipa atopičnih pacijenata nego u tkivu 
polipa neatopičnih pacijenata (p<0,0001), kao i u sluznici pacijenata s alergijskim rinitisom (p<0,0001). 
U nosnoj sluznici pacijenata s alergijskim rinitisom našli smo značajno veći broj eozinofi la nego u polipima 
neatopičnih pacijenata s nosnim polipima (p=0,025). Konačno, našli smo pozitivnu korelaciju između 
nivoa ECP u nosnom sekretu i broja eozinofi la u uzorcima tkiva u sve tri skupine ispitanika. Zaključili 
smo da atopični pacijenti s nosnom polipozom imaju viši stupanj eozinofi lne upale u usporedbi s neatopičnim 
pacijentima s nosnim polipima i s pacijentima s alergijskim rinitisom.
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